This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stanford's Dr. Haruko Akatsu Is Selected For "America's Top Doctors® For Cancer."

Dr. Haruko Akatsu , a Board Certified Stanford , CA physician specializing in Endocrinology, Diabetes & Metabolism, has been selected for America's Top Doctors® for Cancer by Castle Connolly Medical Ltd.

STANFORD, Calif., Dec. 5, 2012 /PRNewswire-USNewswire/ -- Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has published its 8th annual edition of America's Top Doctors® for Cancer and Stanford's Haruko Akatsu , MD has been selected for inclusion.


The 8th edition of America's Top Doctors for Cancer includes over 2,600 top cancer care physicians in the United States. Selected physicians, including Dr. Akatsu, are among the top 1% of cancer doctors in over 40 specialties and subspecialties for the care and treatment of cancer.

Castle Connolly Top Doctors® for Cancer are selected each year by Castle Connolly Medical Ltd. after being nominated by peers in an online nomination process. Nominations are open to all board certified MDs and DOs and each year tens of thousands of physicians cast many tens of thousands of nominations. Nominated physicians are selected by the Castle Connolly physician-led research team based on criteria including medical education, training, hospital appointments, disciplinary histories and much more.

For more information on this Castle Connolly Top Doctor for Cancer, please visit Haruko Akatsu 's profile on

Castle Connolly Medical Ltd.'s President and CEO Dr. John Connolly has this to say about Dr. Akatsu's recognition: "The 8th edition of America's Top Doctors for Cancer , published in November 2012, is the most comprehensive guide of its kind and is the result of contributions from doctors and medical experts from across the United States. Dr. Akatsu was one of more than 2,600 cancer doctors nominated by Board Certified peers and selected by our research team at Castle Connolly Medical Ltd. Selection for the guide is an impressive accomplishment worthy of recognition. The United States is home to so many talented and committed cancer care professionals, yet some stand out. My congratulations to Dr. Akatsu."

To find out more or to contact Dr. Haruko Akatsu of Stanford, CA , please call 650-723-6961.

This press release was written by American Registry, LLC and Castle Connolly Medical Ltd., with approval by and/or contributions from Haruko Akatsu and was distributed by PR Newswire, a subsidiary of UBM plc.

Castle Connolly Medical Ltd. identifies top doctors in America and provides consumers with detailed information about their education, training and special expertise in printed guides and online directories. It is important to note that doctors do not and cannot pay to be included in any Castle Connolly guide or online directory. Learn more at

American Registry, LLC, recognizes excellence in top businesses and professionals. For more information, search The Registry™ at

Contact Info: Dr. Haruko Akatsu Phone: 650-723-6961

SOURCE American Registry

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs